Linezolid in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream Infections

Phase 3 Terminated 61 enrolled Pfizer

RandomizedParallel-groupOpen-labelTreatment

Summary

This study will treat hemodialysis patients who have a central catheter that is thought to be infected with a specific bacteria (Gram positive bacteria).

Timeline

Start: 2005-09
Primary completion: —
Completion: 2006-09

Outcome

Outcome not reported

Stopped: “See Detailed Description”

Publications

Almeida BM, Moreno DH, Vasconcelos V, Cacione DG. Interventions for treating catheter-related bloodstream infections in people receiving maintenance haemodialysis. Cochrane Database Syst Rev. 2022 Apr 1;4(4):CD013554. doi: 10.1002/14651858.CD013554.pub2.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Cefazolin	Small molecule	—	Intravenous
Subject	Linezolid	Other / unclassified	—	Intravenous
Subject	Vancomycin	Other / unclassified	—	Intravenous